Scientists propose repurposing anti-malarial drug Mefloquine to fight COVID-19

Japanese scientists are scanning the possibility of using an anti-malarial drug called mefloquine....

July 2, 2021 | Friday | News
Japan's Sysmex Corp teams up with QIAGEN for global cancer companion diagnostics

QIAGEN has announced a global strategic alliance with Japan’s Sysmex Corporation for the development and commercia...

July 2, 2021 | Friday | News
Japan plans data scientist training program for pharma industry

Japanese firms Chugai Pharmaceutical Co., Ltd. and ALBERT Inc, have jointly developed a data scientist training program ...

June 29, 2021 | Tuesday | News
Japanese startup B dot Medical promotes spread of proton therapy

B dot Medical Inc., a startup based in Japan, has confirmed the superconductivity of a superconducting bending magnet de...

June 28, 2021 | Monday | News
Takara Bio grants BioNTech a commercial patents license of CAR T-cell Therapy drug

Takara Bio Inc. world leader in biotechnology R&D, announces that it has entered into a License and Supply Agre...

June 25, 2021 | Friday | News
Japan aims to prevent CVDs using AI and home measurement data

OMRON Healthcare and Kyoto University have announced a new Collaborative Research Program called "Healthc...

June 25, 2021 | Friday | News
Japanese healthcare firms to find potential startup partners at virtual convention

The Japan External Trade Organization (JETRO) has announced that 12 major Japanese corporate venture capital g...

June 24, 2021 | Thursday | News
Fujitsu Japan deploys world's fastest supercomputer for COVID-19 therapies

Fujitsu Japan has announced that it will initiate a new research project with a research team led by Japan's Resear...

June 22, 2021 | Tuesday | News
Rakuten Medical, Shimadzu to develop photoimmunotherapy-based medical device

Rakuten Medical, Inc. and Shimadzu Corporation, with operations in both Japan & US, have announced a joint...

June 18, 2021 | Friday | News
Daiichi Sankyo discontinues development of Nafamostat in Japan for COVID-19 treatment

Japanese pharma firm Daiichi Sankyo Company has announced that it has decided to discontinue development of nafamostat i...

June 16, 2021 | Wednesday | News
Japan demonstrates ability of chlorine dioxide aqueous solution to combat SARS-CoV-2

Taiko Pharmaceutical based in Osaka, Japan, has announced that long-lasting chlorine dioxide (ClO2) aqueous solutio...

June 11, 2021 | Friday | News
Japan's Eisai helps Alzheimer’s patients access ADUHELM post-FDA approval

Following U.S. Food and Drug Administration’s (FDA) accelerated approval of ADUHELMTM (aducanumab-avwa) as th...

June 8, 2021 | Tuesday | News
Japan hosts Gavi COVAX AMC summit virtual event securing $2.4 B

World leaders joined forces on 2 June at the “One World Protected” - Gavi COVAX Advance Market Commitme...

June 7, 2021 | Monday | News
Countries, health partners discuss efforts to curb COVID-19 in WHO South-East Asia Region

The World Health Organization convened a meeting of member countries and health partners to discuss the strengthening of...

June 3, 2021 | Thursday | News
Eisai ties up with ITO EN to support people living with dementia

Tokyo-headquartered Eisai Co and ITO EN have entered into a business alliance agreement concerning the initiatives for s...

June 2, 2021 | Wednesday | News
Shimadzu and Shionogi partner to explore wastewater viral infections

Japanese firms Shimadzu Corporation and Shionogi & Co. have inked the basic agreement of business partnership to tar...

June 3, 2021 | Thursday | News
Japan takes step forward towards treating hereditary deafness

Researchers at Juntendo University in Japan report in the journal Human Molecular Genetics that a stem-cell te...

May 31, 2021 | Monday | News
Fujitsu Japan revamps Electronic Medical Record System for clinics

Fujitsu Japan to support a wide range of doctors' work, such as treatment of chronic diseases and medical treatment...

May 31, 2021 | Monday | News